Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or ...
Patients undergoing stereotactic radiosurgery before resection of brain metastases demonstrated low rates of local recurrence, radionecrosis, and nodular leptomeningeal disease at 12 and 24 months, a ...
Decisions around screening for brain metastases in patients with metastatic breast cancer (MBC) can be challenging. To shed some light on the latest screening guidelines and their implications for ...
Brain metastases arising from gynecologic cancers, including ovarian, endometrial and cervical malignancies, present unique diagnostic and therapeutic challenges. Although these metastatic events are ...
Asymptomatic brain metastasis in stage 4 breast cancer requires reevaluation of screening guidelines
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study, published in ...
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv University, has uncovered a mechanism that allows breast cancer to send ...
A recent Tampa, Fla.-based Moffitt Cancer Center study found that up to 25% of patients with stage 4 breast cancer may develop asymptomatic brain metastasis. The study, published Jan. 24 in ...
The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...
Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...
Please provide your email address to receive an email when new articles are posted on . Sacituzumab govitecan-hziy exhibited efficacy as therapy for two traditionally difficult-to-treat populations, ...
Brain metastases are a common problem in patients with EGFR-mutated non-small cell lung cancer (NSCLC), occurring in about one-fifth to one-quarter of patients. Many brain metastases will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results